Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Meloxicam (Mobic) is used to treat pain or inflammation caused by osteoarthritis or rheumatoid arthritis.
The report details the trend, potential and market size of Meloxicam Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Meloxicam Drugmarket, defines the market attractiveness level of Meloxicam Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Meloxicam Drug industry, describes the types of Meloxicam Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Meloxicam Drug market and the development prospects and opportunities of Meloxicam Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Meloxicam Drug market in Chapter 13.
By Player:
Boehringer-Ingelheim
PuraCap Pharmaceutical
Glenmark Pharmaceuticals
Zydus Pharmaceuticals
Aurobindo Pharma
TerSera Therapeutics
Yung Shin Pharmaceutical
Cipla
Dr Reddy's Laboratories
Unichem Pharmaceuticals
Apotex
Breckenridge Pharmaceutical
Lupin Pharmaceuticals
Teva
Iroko Pharmaceuticals
Strides Pharma
TARO
By Type:
Tablet
Capsule
By End-User:
Osteoarthritis in adults (OA)
Rheumatoid Arthritis in adults (RA)
Pediatric patients
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Meloxicam Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Meloxicam Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Meloxicam Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Meloxicam Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Meloxicam Drug Market Analysis and Outlook to 2022
-
7.1 Global Meloxicam Drug Consumption (2017-2022)
-
7.2 United States Meloxicam Drug Consumption (2017-2022)
-
7.3 Europe Meloxicam Drug Consumption (2017-2022)
-
7.4 China Meloxicam Drug Consumption (2017-2022)
-
7.5 Japan Meloxicam Drug Consumption (2017-2022)
-
7.6 India Meloxicam Drug Consumption (2017-2022)
-
7.7 South Korea Meloxicam Drug Consumption (2017-2022)
8 Region and Country-wise Meloxicam Drug Market Analysis and Outlook to 2028
-
8.1 Global Meloxicam Drug Consumption Forecast (2022-2028)
-
8.2 United States Meloxicam Drug Consumption Forecast (2022-2028)
-
8.3 Europe Meloxicam Drug Consumption Forecast (2022-2028)
-
8.4 China Meloxicam Drug Consumption Forecast (2022-2028)
-
8.5 Japan Meloxicam Drug Consumption Forecast (2022-2028)
-
8.6 India Meloxicam Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Meloxicam Drug Consumption Forecast (2022-2028)
9 Global Meloxicam Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Meloxicam Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tablet Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Capsule Consumption and Growth Rate (2017-2022)
-
9.2 Global Meloxicam Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Osteoarthritis in adults (OA) Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Rheumatoid Arthritis in adults (RA) Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Pediatric patients Consumption and Growth Rate (2017-2022)
10 Global Meloxicam Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Meloxicam Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Tablet Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Capsule Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Meloxicam Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Osteoarthritis in adults (OA) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Rheumatoid Arthritis in adults (RA) Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Pediatric patients Consumption Forecast and Growth Rate (2022-2028)
11 Global Meloxicam Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Meloxicam Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Meloxicam Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Meloxicam Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Meloxicam Drug Market Competitive Analysis
-
14.1 Boehringer-Ingelheim
-
14.1.1 Boehringer-Ingelheim Company Details
-
14.1.2 Boehringer-Ingelheim Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Boehringer-Ingelheim Meloxicam Drug Product and Service
-
14.2 PuraCap Pharmaceutical
-
14.2.1 PuraCap Pharmaceutical Company Details
-
14.2.2 PuraCap Pharmaceutical Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 PuraCap Pharmaceutical Meloxicam Drug Product and Service
-
14.3 Glenmark Pharmaceuticals
-
14.3.1 Glenmark Pharmaceuticals Company Details
-
14.3.2 Glenmark Pharmaceuticals Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Glenmark Pharmaceuticals Meloxicam Drug Product and Service
-
14.4 Zydus Pharmaceuticals
-
14.4.1 Zydus Pharmaceuticals Company Details
-
14.4.2 Zydus Pharmaceuticals Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Zydus Pharmaceuticals Meloxicam Drug Product and Service
-
14.5 Aurobindo Pharma
-
14.5.1 Aurobindo Pharma Company Details
-
14.5.2 Aurobindo Pharma Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Aurobindo Pharma Meloxicam Drug Product and Service
-
14.6 TerSera Therapeutics
-
14.6.1 TerSera Therapeutics Company Details
-
14.6.2 TerSera Therapeutics Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 TerSera Therapeutics Meloxicam Drug Product and Service
-
14.7 Yung Shin Pharmaceutical
-
14.7.1 Yung Shin Pharmaceutical Company Details
-
14.7.2 Yung Shin Pharmaceutical Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Yung Shin Pharmaceutical Meloxicam Drug Product and Service
-
14.8 Cipla
-
14.8.1 Cipla Company Details
-
14.8.2 Cipla Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Cipla Meloxicam Drug Product and Service
-
14.9 Dr Reddy's Laboratories
-
14.9.1 Dr Reddy's Laboratories Company Details
-
14.9.2 Dr Reddy's Laboratories Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Dr Reddy's Laboratories Meloxicam Drug Product and Service
-
14.10 Unichem Pharmaceuticals
-
14.10.1 Unichem Pharmaceuticals Company Details
-
14.10.2 Unichem Pharmaceuticals Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Unichem Pharmaceuticals Meloxicam Drug Product and Service
-
14.11 Apotex
-
14.11.1 Apotex Company Details
-
14.11.2 Apotex Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Apotex Meloxicam Drug Product and Service
-
14.12 Breckenridge Pharmaceutical
-
14.12.1 Breckenridge Pharmaceutical Company Details
-
14.12.2 Breckenridge Pharmaceutical Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Breckenridge Pharmaceutical Meloxicam Drug Product and Service
-
14.13 Lupin Pharmaceuticals
-
14.13.1 Lupin Pharmaceuticals Company Details
-
14.13.2 Lupin Pharmaceuticals Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Lupin Pharmaceuticals Meloxicam Drug Product and Service
-
14.14 Teva
-
14.14.1 Teva Company Details
-
14.14.2 Teva Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 Teva Meloxicam Drug Product and Service
-
14.15 Iroko Pharmaceuticals
-
14.15.1 Iroko Pharmaceuticals Company Details
-
14.15.2 Iroko Pharmaceuticals Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Iroko Pharmaceuticals Meloxicam Drug Product and Service
-
14.16 Strides Pharma
-
14.16.1 Strides Pharma Company Details
-
14.16.2 Strides Pharma Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Strides Pharma Meloxicam Drug Product and Service
-
14.17 TARO
-
14.17.1 TARO Company Details
-
14.17.2 TARO Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.17.3 TARO Meloxicam Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Meloxicam Drug
-
Figure Meloxicam Drug Picture
-
Table Global Meloxicam Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Meloxicam Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Meloxicam Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Meloxicam Drug Consumption by Country (2017-2022)
-
Figure United States Meloxicam Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Meloxicam Drug Consumption and Growth Rate (2017-2022)
-
Figure China Meloxicam Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Meloxicam Drug Consumption and Growth Rate (2017-2022)
-
Figure India Meloxicam Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Meloxicam Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Meloxicam Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Meloxicam Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Meloxicam Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Meloxicam Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Meloxicam Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Meloxicam Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Meloxicam Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tablet Consumption and Growth Rate (2017-2022)
-
Figure Global Capsule Consumption and Growth Rate (2017-2022)
-
Figure Global Osteoarthritis in adults (OA) Consumption and Growth Rate (2017-2022)
-
Figure Global Rheumatoid Arthritis in adults (RA) Consumption and Growth Rate (2017-2022)
-
Figure Global Pediatric patients Consumption and Growth Rate (2017-2022)
-
Figure Global Tablet Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Capsule Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Osteoarthritis in adults (OA) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rheumatoid Arthritis in adults (RA) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pediatric patients Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Meloxicam Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Meloxicam Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Boehringer-Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer-Ingelheim Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer-Ingelheim Meloxicam Drug Product and Service
-
Table PuraCap Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table PuraCap Pharmaceutical Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table PuraCap Pharmaceutical Meloxicam Drug Product and Service
-
Table Glenmark Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Glenmark Pharmaceuticals Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Glenmark Pharmaceuticals Meloxicam Drug Product and Service
-
Table Zydus Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Zydus Pharmaceuticals Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zydus Pharmaceuticals Meloxicam Drug Product and Service
-
Table Aurobindo Pharma (Foundation Year, Company Profile and etc.)
-
Table Aurobindo Pharma Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aurobindo Pharma Meloxicam Drug Product and Service
-
Table TerSera Therapeutics (Foundation Year, Company Profile and etc.)
-
Table TerSera Therapeutics Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table TerSera Therapeutics Meloxicam Drug Product and Service
-
Table Yung Shin Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Yung Shin Pharmaceutical Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Yung Shin Pharmaceutical Meloxicam Drug Product and Service
-
Table Cipla (Foundation Year, Company Profile and etc.)
-
Table Cipla Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Meloxicam Drug Product and Service
-
Table Dr Reddy's Laboratories (Foundation Year, Company Profile and etc.)
-
Table Dr Reddy's Laboratories Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dr Reddy's Laboratories Meloxicam Drug Product and Service
-
Table Unichem Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Unichem Pharmaceuticals Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Unichem Pharmaceuticals Meloxicam Drug Product and Service
-
Table Apotex (Foundation Year, Company Profile and etc.)
-
Table Apotex Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Apotex Meloxicam Drug Product and Service
-
Table Breckenridge Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Breckenridge Pharmaceutical Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Breckenridge Pharmaceutical Meloxicam Drug Product and Service
-
Table Lupin Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Lupin Pharmaceuticals Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Lupin Pharmaceuticals Meloxicam Drug Product and Service
-
Table Teva (Foundation Year, Company Profile and etc.)
-
Table Teva Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Meloxicam Drug Product and Service
-
Table Iroko Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Iroko Pharmaceuticals Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Iroko Pharmaceuticals Meloxicam Drug Product and Service
-
Table Strides Pharma (Foundation Year, Company Profile and etc.)
-
Table Strides Pharma Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Strides Pharma Meloxicam Drug Product and Service
-
Table TARO (Foundation Year, Company Profile and etc.)
-
Table TARO Meloxicam Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table TARO Meloxicam Drug Product and Service
-
